Elicera Therapeutics enrolls the last patient in the clinical phase I/II-trial with oncolytic virus ELC-100
Gothenburg, October 24, 2024 – Elicera Therapeutics AB (publ), a clinical stage
Interim report 2024, January 1–September 30
The third quarter of 2024 showed strong order intake, +17%, and
Bulletin from the extraordinary general meeting on 23 October 2024 in Chosa Oncology AB
The English text is an unofficial translation. In case of any
Metsä Group Kemi bioproduct mill inaugurated
Metsä Group marked the inauguration of the bioproduct mill in
Holding(s) in Company – Oscillate Plc
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in
Helping make more sustainable snacks
Experts from Teesside University are helping make one of the UK’s most
Relais Group Plc: Share Repurchase 23.10.2024
Relais Group Plc ANNOUNCEMENT 23.10.2024 Relais Group Plc: Share Repurchase 23.10.2024 In the Helsinki Stock Exchange
How Tradespeople Can Use Social Media to Find More Clients
Social media has quickly become a very integral part of
Stendörren evaluates the conditions to carry out a directed share issue of B shares of approximately SEK 500 million
Press release 23 October 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR
Fondia Plc: Share repurchase 23.10.2024
Fondia Plc Company release 23.10.2024 at 6.45 p.m. EEST Fondia